Public Offering	6 Months Ended
Sep. 30, 2021
Public Offering
Public Offering	Note 3 — Public Offering On November 9, 2021 the Company consummated the sale of 20,000,000 Units, (or 23,000,000 Units if the underwriters’ over-allotment option is exercised in full) at a price of $10.00 per Unit. On November 12, 2021, the underwriters exercised their full over-allotment option which resulted in the sale of an additional 3,000,000 Units for an aggregate of 23,000,000 Units (see Note 8). Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable 30 days after the completion of the initial Business Combination, and will expire at 5:00 p.m., New York City time, five years after the completion of the initial Business Combination or earlier upon redemption or liquidation.

Public Offering

6 Months Ended

Sep. 30, 2021

Note 3 — Public Offering

On November 9, 2021 the Company consummated the sale of 20,000,000 Units, (or 23,000,000 Units if the underwriters’ over-allotment option is exercised in full) at a price of $10.00 per Unit. On November 12, 2021, the underwriters exercised their full over-allotment option which resulted in the sale of an additional 3,000,000 Units for an aggregate of 23,000,000 Units (see Note 8).

Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable 30 days after the completion of the initial Business Combination, and will expire at 5:00 p.m., New York City time, five years after the completion of the initial Business Combination or earlier upon redemption or liquidation.